Development of an early biomarker for the ovarian liability of selective estrogen receptor modulators in rats
β Scribed by Heather A. Harris; Vargheese M. Chennathukuzhi; Xiaochun Zhang; Belew Mekonnen; Scott A. Jelinsky; Scott H. Schelling; Vikram S. Patel; Christine Huselton; Andre Negahban; Farooq Azam; Richard C. Winneker
- Book ID
- 116698237
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 624 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0960-0760
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A sensitive LC/MS/MS method has been developed by derivatization of 17Ξ²βestradiol (E2) with dansyl chloride to quantitate 17Ξ²βE2 in female rat serum. The use of E2βd~5~ minimized interferences from endogenous 17Ξ²βE2 in order to achieve a limit of quantitation (LOQ) of 2.5 pg/ml using 15
Raloxifene i s a selective estrogen receptor modulator known to have antiestrogenic effects o n uterine tissue. In this study, the effects of raloxifene on uterine explant growth were evaluated in rats. Rats were ovariectomized, implanted with an estradiol pellet, and an endometriosis-like state was